Paper · 39722698
sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden.
Jiao L and 5 others. Front Neurol, 2024. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden. Papers, record 39722698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39722698
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,116,464 | Amyotrophic lateral sclerosis. | Lancet | 2022 | https://conductscience.org/library/papers/36116464 | PubMed |
| 2 | 27,995,062 | Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis. | Neuroimage Clin | 2016 | https://conductscience.org/library/papers/27995062 | PubMed |
| 3 | 38,647,181 | Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptoms. | Ann Clin Transl Neurol | 2024 | https://conductscience.org/library/papers/38647181 | PubMed |
| 4 | 35,806,270 | Iron, Neuroinflammation and Neurodegeneration. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806270 | PubMed |
| 5 | 36,408,515 | The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer's continuum. | Front Neurol | 2022 | https://conductscience.org/library/papers/36408515 | PubMed |
| 6 | 16,434,671 | Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. | Neurology | 2006 | https://conductscience.org/library/papers/16434671 | PubMed |
| 7 | 11,464,847 | El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. | Amyotroph Lateral Scler Other Motor Neuron Disord | 2000 | https://conductscience.org/library/papers/11464847 | PubMed |
| 8 | 28,651,542 | Evidence for an early innate immune response in the motor cortex of ALS. | J Neuroinflammation | 2017 | https://conductscience.org/library/papers/28651542 | PubMed |
| 9 | 26,941,262 | sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. | EMBO Mol Med | 2016 | https://conductscience.org/library/papers/26941262 | PubMed |
| 10 | 36,681,358 | Profiling TREM2 expression in amyotrophic lateral sclerosis. | Brain Behav Immun | 2023 | https://conductscience.org/library/papers/36681358 | PubMed |
1 to 10 of 33
See all 33 referencesCited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,865,133 | Context-dependent TREM2 signalling in myeloid cells: Molecular mechanisms and immunotherapeutic divergence in neurodegeneration and cancer. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42865133 | PubMed |
| 42,694,654 | TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/42694654 | PubMed |
| 42,582,058 | Revisiting TREM2: from multi-omics signaling networks to clinical translation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42582058 | PubMed |
| 42,458,498 | TREM2 in neurodegenerative diseases and acute neurological injuries: mechanisms to targeted therapies. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42458498 | PubMed |
| 42,382,745 | The TREM2 paradox in fibrosis: a unified mechanism for opposite outcomes across organs. | Front Immunol | 2026 | https://conductscience.org/library/papers/42382745 | PubMed |
| 42,359,357 | Innate immune crosstalk in ALS/FTD pathogenesis. | Cell Insight | 2026 | https://conductscience.org/library/papers/42359357 | PubMed |
| 41,533,211 | TREM2-mediated Crosstalk in ALS: Microglial Fate Transition, Protein Aggregate Clearance, and Peripheral Nerve Repair. | Neurosci Bull | 2026 | https://conductscience.org/library/papers/41533211 | PubMed |
| 41,530,159 | Parkinson's disease: spatiotemporal regulation and therapeutic prospects of TREM2-mediated microglial responses. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41530159 | PubMed |
| 41,449,430 | Role of TREM2 in neuroinflammation regulation: mechanisms, disease associations, and therapeutic translation advances. | J Transl Med | 2025 | https://conductscience.org/library/papers/41449430 | PubMed |
| 41,096,792 | The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and Debates. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096792 | PubMed |
1 to 10 of 13
See all 13 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NEFL | 4,747 | PubTator's text mining | https://conductscience.org/library/genes/4747 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39722698
GET https://conductscience.org/api/papers/v1/39722698/references?page=2